For YY1, we also predicted increased transcriptional activity predominantly at the early time points and this effect was diminished at later time points; so far, a role for this transcription factor in COPD has been observed only in COPD-associated skeletal muscle atrophy, but not in lung tissue [69]. The gene discussed is YY1; the disease is chronic obstructive pulmonary disease.